MRI-Guided Targeted and Systematic Prostate Biopsies as Prognostic Indicators for Prostate Cancer Treatment Decisions

SIMPLE SUMMARY: The term “clinically relevant prostate carcinoma” (csPCa) is used to differentiate the types of prostate carcinoma (PCa) that can lead to the death of the affected patient from those tumor types that usually do not. Targeted biopsies (TBx) of visible lesions in an MRI of the prostate...

Descripción completa

Detalles Bibliográficos
Autores principales: Abd Ali, Furat, Sievert, Karl-Dietrich, Eisenblaetter, Michel, Titze, Barbara, Hansen, Torsten, Barth, Peter J., Titze, Ulf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416861/
https://www.ncbi.nlm.nih.gov/pubmed/37568731
http://dx.doi.org/10.3390/cancers15153915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10416861/
https://www.ncbi.nlm.nih.gov/pubmed/37568731
http://dx.doi.org/10.3390/cancers15153915

Ejemplares similares